New Delhi: Daiichi Sankyo and Ranbaxy will work in synergy in Brazil to expand the business of both companies in the cou...
Singapore: Japan's technology company, Arkray is investing $9.1 million over a five-year period in a research venture an...
Singapore: Fujifilm Corporation has started full-scale operation of Fujifilm Optics Philippines in Laguna. The new compa...
Singapore: National Cancer Center of Japan and pharma company Daiichi Sankyo have agreed to form a comprehensive resear...
Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high calib...
Singapore: BIOtech 2013 in Japan, which is one-of-the-largest bio events in Asia, concluded successfully. The event was ...
Singapore: Mystic Pharmaceuticals, US, received key notices of allowance from Asian patent offices in the company's ong...
‎Singapore: TriReme Medical's Japanese partner, Century Medical, has received Shonin approval for Glider PTCA cath...
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: Ariad Pharmaceuticals, an emerging global oncology company focused on discovery, development and commercializ...
Singapore: Eisai has been able to meet the US FDA's written request requirements for pediatric exclusivity for Aciphex ...
Singapore: Abbott announced that it has initiated the Absorb Japan randomized controlled clinical trial to evaluate the ...
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...
Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...
Singapore: Chugai Pharma USA, Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical, Tokyo, Japan, mem...
Singapore: Japan is hosting its first personalised medicine and diagnostics expo in May 14-16, 2014.The Japanese governm...
The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...
Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...
